Talk:Giant-cell tumor of the tendon sheath

It is requested that a photograph be included in this article to improve its quality.
The external tool WordPress Openverse may be able to locate suitable images on Flickr and other web sites.

Upload

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Giant-cell tumor of the tendon sheath.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Article categorization

This article was categorized based on scheme outlined at WP:DERM:CAT. kilbad (talk) 16:45, 27 December 2008 (UTC)[reply]

Edit Request

This edit request by an editor with a conflict of interest has now been answered.

NOTE: I am proposing this edit for FleishmanHillard on behalf of Daiichi Sankyo. I am a paid editor and am aware of the COI guidelines.

I am submitting this edit request to bring your attention to the fact that the World Health Organization reclassified pigmented villonodular synovitis (PVNS) and giant-cell tumor of the tendon sheath (GCT-TS) to “tenosynovial giant cell tumor” or “TGCT” in 2013 in its 4th edition of WHO Classification of Tumours of Soft Tissue and Bone ^[1] (paid subscription required) to encompass a family of lesions in the soft tissue surrounding large & small joints, which all share a common pathogenesis.

As you know, this is a rare disease with very limited online resources, and the scientific and medical community are continually learning more about the condition. There are several resources containing information about TGCT, and a few are provided below, which should not be considered all-inclusive. Publications about TGCT have been posted by:

National Institutes of Health (The Patient Perspective on the Impact of Tenosynovial Giant Cell Tumors on Daily Living: Crowdsourcing Study on Physical Function and Quality of Life ^[2]; Localized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis) ^[3].

Clinicaltrials.gov, where you can see that TGCT trials ^[4] include both PVNS trials ^[5] and giant cell tumor of the tendon sheath trials ^[6].

We gather it is your objective to ensure the community has as much accurate and up-to-date information possible. Toward that end, we’re requesting that the existing GCT-TS page be updated to include “TGCT” as an overarching name for the condition as adopted by the World Health Organization and the National Organization for Rare Disorders.

Thank you for your consideration. Jon Gray (talk) 22:55, 31 October 2018 (UTC)[reply]

References

^ Fletcher, C. D.M.; Bridge, J.A.; Hogendoorn, P.; Mertens, F. (2013). WHO Classification of Tumours of Soft Tissue and Bone. Fourth Edition. World Health Organization. p. 100-103. ISBN 9789283224341.
^ Monique Josephine Mastboom, MD, Rosa Planje, BSc and Michiel Adreanus van de Sande, MD (February 23, 2018). "The Patient Perspective on the Impact of Tenosynovial Giant Cell Tumors on Daily Living: Crowdsourcing Study on Physical Function and Quality of Life". National Institutes of Health. Retrieved October 24, 2018. Tenosynovial giant cell tumor (TGCT), previously pigmented villonodular synovitis (PVNS), is a rare, proliferative neoplasm affecting the synovial lining of joints, bursae, and tendons sheaths. {{cite journal}}: Cite journal requires |journal= (help)CS1 maint: multiple names: authors list (link)
^ Gouin F., Noailles, T. (February 2017). "Localized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis)". National Institutes of Health. Retrieved October 24, 2018. {{cite journal}}: Cite journal requires |journal= (help)CS1 maint: multiple names: authors list (link)
^ . Clinicaltrials.gov https://clinicaltrials.gov/ct2/results?cond=&term=tenosynovial+giant+cell+tumor&cntry=&state=&city=&dist. Retrieved October 24, 2018. {{cite web}}: Missing or empty |title= (help)
^ . Clinicaltrials.gov https://clinicaltrials.gov/ct2/results?cond=&term=pigmented+villonodular+synovitis&cntry=&state=&city=&dist=. Retrieved October 24, 2018. {{cite web}}: Missing or empty |title= (help)
^ . Clinicaltrials.gov https://clinicaltrials.gov/ct2/results?cond=giant+cell+tumor+of+the+tendon+sheath&term=&cntry=&state=&city=&dist. Retrieved October 24, 2018. {{cite web}}: Missing or empty |title= (help)

Reply 01-NOV-2018

Clarification requested

If your request is to change the article's title, those requests should be submitted using {{requested move}} specifically as a controversial move request process requiring discussion amongst the wider community. More information may be found at requested moves.
If your request is to change the instance of the word in certain areas of the article, please propose verbatim the changes here on the talk page.

If choice number two above is your intention, kindly change the {{request edit}} template's answer parameter to read from |ans=yes to |ans=no
Regards, Spintendo 07:56, 1 November 2018 (UTC)[reply]

Clarification on Edit Request

This edit request by an editor with a conflict of interest was declined. Per MOS:LEADLINK.

NOTE: I am proposing this edit for FleishmanHillard on behalf of Daiichi Sankyo. I am a paid editor and am aware of the COI guidelines.

@Spintendo: As a follow up to your request for clarification, our request is submitted with the intention of adding a passage to the existing first sentence of the page which introduces localized tenosynovial giant cell tumor as an alternate name for giant-cell tumor of the tendon sheath. Requested verbatim addition (bolded) and sourcing follow:

Giant-cell tumor of the tendon sheath, also known as giant-cell synovioma, localized nodular tenosynovitis and localized tenosynovial giant cell tumor or TGCT^[1] is a firm lesion, measuring 1 to 3 cm in diameter, and is most commonly attached to the tendons of the fingers, hands, and wrists, with a predilection for the flexor surfaces.

Also, as giant-cell tumor of the tendon sheath and pigmented villonodular synovitis are related conditions, we also would like to request that the “See also” section of this page be updated to include a link to the pigmented villonodular synovitis Wikipedia page. The “See also” section of pigmented villonodular synovitis page has a link to the giant-cell tumor of the tendon sheath Wikipedia page, so we’re hoping to add a cross-link here so people who are learning about the related conditions can quickly access additional information about each disease. Thank you for your consideration. Jon Gray (talk) 16:06, 6 December 2018 (UTC)[reply]

References

^ Fletcher, C. D.M.; Bridge, J.A.; Hogendoorn, P.; Mertens, F. (2013). WHO Classification of Tumours of Soft Tissue and Bone. Fourth Edition. World Health Organization. p. 100. ISBN 9789283224341. This family of lesions includes the localized giant cell tumour of tendon sheath/tenosynovial giant cell tumour, and the more diffuse and destructive variant called diffuse-type giant cell tumour/pigmented villonodular synovitis.

Reply 06-DEC-2018

Edit request declined

In technical articles that use uncommon terms, a higher-than-usual link density in the lead section may be necessary. But the function of links is to clarify, not emphasize. Guidance suggests in those cases that the wording should provide an informal explanation in the lead first, thereby avoiding the use of too many technical terms until later in the article.^[1]
See also Wikipedia:Make technical articles understandable and point 7 of Wikipedia:What Wikipedia is not § Wikipedia is not a manual, guidebook, textbook, or scientific journal

Regards, Spintendo 02:02, 7 December 2018 (UTC)[reply]

References

^ "MOS:LEADLINK". Wikipedia. 20 November 2018.

[1] Fletcher, C. D.M.; Bridge, J.A.; Hogendoorn, P.; Mertens, F. (2013). WHO Classification of Tumours of Soft Tissue and Bone. Fourth Edition. World Health Organization. p. 100-103. ISBN 9789283224341.

[2] Monique Josephine Mastboom, MD, Rosa Planje, BSc and Michiel Adreanus van de Sande, MD (February 23, 2018). "The Patient Perspective on the Impact of Tenosynovial Giant Cell Tumors on Daily Living: Crowdsourcing Study on Physical Function and Quality of Life". National Institutes of Health. Retrieved October 24, 2018. Tenosynovial giant cell tumor (TGCT), previously pigmented villonodular synovitis (PVNS), is a rare, proliferative neoplasm affecting the synovial lining of joints, bursae, and tendons sheaths. {{cite journal}}: Cite journal requires |journal= (help)CS1 maint: multiple names: authors list (link)

[3] Gouin F., Noailles, T. (February 2017). "Localized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis)". National Institutes of Health. Retrieved October 24, 2018. {{cite journal}}: Cite journal requires |journal= (help)CS1 maint: multiple names: authors list (link)

[4] . Clinicaltrials.gov https://clinicaltrials.gov/ct2/results?cond=&term=tenosynovial+giant+cell+tumor&cntry=&state=&city=&dist. Retrieved October 24, 2018. {{cite web}}: Missing or empty |title= (help)

[5] . Clinicaltrials.gov https://clinicaltrials.gov/ct2/results?cond=&term=pigmented+villonodular+synovitis&cntry=&state=&city=&dist=. Retrieved October 24, 2018. {{cite web}}: Missing or empty |title= (help)

[6] . Clinicaltrials.gov https://clinicaltrials.gov/ct2/results?cond=giant+cell+tumor+of+the+tendon+sheath&term=&cntry=&state=&city=&dist. Retrieved October 24, 2018. {{cite web}}: Missing or empty |title= (help)

[7] Fletcher, C. D.M.; Bridge, J.A.; Hogendoorn, P.; Mertens, F. (2013). WHO Classification of Tumours of Soft Tissue and Bone. Fourth Edition. World Health Organization. p. 100. ISBN 9789283224341. This family of lesions includes the localized giant cell tumour of tendon sheath/tenosynovial giant cell tumour, and the more diffuse and destructive variant called diffuse-type giant cell tumour/pigmented villonodular synovitis.

[8] "MOS:LEADLINK". Wikipedia. 20 November 2018.

[1]

[2]

[3]

[4]

[5]

[6]

[1]

[1]